Annual report pursuant to Section 13 and 15(d)


Cover - USD ($)
12 Months Ended
Dec. 31, 2021
Apr. 13, 2022
Jun. 30, 2021
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2021    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2021    
Current Fiscal Year End Date --12-31    
Entity File Number 000-55453    
Entity Registrant Name ENDONOVO THERAPEUTICS, INC.    
Entity Central Index Key 0001528172    
Entity Tax Identification Number 45-2552528    
Entity Incorporation, State or Country Code DE    
Entity Address, Address Line One 6320 Canoga Avenue    
Entity Address, Address Line Two 15th Floor    
Entity Address, City or Town Woodland Hills    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 91367    
City Area Code (800)    
Local Phone Number 489-4774    
Trading Symbol ENDV    
Title of 12(g) Security Common stock, par value $0.0001    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Public Float     $ 2,304,075
Entity Common Stock, Shares Outstanding   149,527,538  
Documents Incorporated by Reference None    
ICFR Auditor Attestation Flag false    
Auditor Firm ID 468    
Auditor Name Rose, Snyder & Jacobs LLP    
Auditor Location Encino, CA